Furthermore, in a tumor model, Wroblewski et al. [80] demonstrated that mast cell degranulation, and specifically GzmB released from mast cells, promotes angiogenesis by decreasing the efficacy of anti-angiogenic agents in a tumor model. Here, GZMB is linked to neoplasm.